Your browser doesn't support javascript.
loading
Research progresses on relationship between Wnt inhibitory factor-1 and tumor / 中国癌症杂志
China Oncology ; (12)1998.
Article in Zh | WPRIM | ID: wpr-548594
Responsible library: WPRO
ABSTRACT
WIF-1 is an important antagonist in the Wnt/?-catenin pathway.As a tumor suppressor, WIF-1 is down-regulated in majority cancers but when it is correlated with WIF-1 promoter hypermethylation and treated with demethylation drug, its expression can be restored.Functional loss of WIF-1 due to promoter hypermethylation plays an important role in a tumor's pathogenesis, possibly mainly through aberrant canonical Wnt/?-catenin signal activation.The correlation of the expression of WIF-1 with clinicopathological features in different cancers is not identical.Detecting WIF-1 and promoter hypermethylation may offer help for early diagnosis, therapy and predicting prognoses.
Key words
Full text: 1 Database: WPRIM Type of study: Prognostic_studies / Screening_studies Language: Zh Journal: China Oncology Year: 1998 Document type: Article
Full text: 1 Database: WPRIM Type of study: Prognostic_studies / Screening_studies Language: Zh Journal: China Oncology Year: 1998 Document type: Article